Form 8-K - Current report:
SEC Accession No. 0000950170-24-131609
Filing Date
2024-11-27
Accepted
2024-11-27 17:12:04
Documents
11
Period of Report
2024-11-27
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K acet-20241127.htm   iXBRL 8-K 38652
  Complete submission text file 0000950170-24-131609.txt   152009

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20241127.xsd EX-101.SCH 25038
14 EXTRACTED XBRL INSTANCE DOCUMENT acet-20241127_htm.xml XML 4753
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 241512361
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)